D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lowe's Companies
LOW
|
+$638M |
| 2 |
NVIDIA
NVDA
|
+$461M |
| 3 |
EQT Corp
EQT
|
+$400M |
| 4 |
Citigroup
C
|
+$369M |
| 5 |
CELG
Celgene Corp
CELG
|
+$339M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$694M |
| 2 |
Dell
DELL
|
+$486M |
| 3 |
IBM
IBM
|
+$341M |
| 4 |
Amgen
AMGN
|
+$306M |
| 5 |
Johnson & Johnson
JNJ
|
+$264M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.05% |
| 2 | Healthcare | 10.49% |
| 3 | Consumer Discretionary | 10.21% |
| 4 | Financials | 8.38% |
| 5 | Industrials | 7.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2201
Inovio Pharmaceuticals
INO
$81M
| $1.47M | ﹤0.01% |
26,052
+3,594
| +16% | +$195K |
|
2202
Northrop Grumman
NOC
$78.1B
| $1.47M | ﹤0.01% |
4,207
+2,410
| +134% | +$807K |
|
|
DQ
2203
Daqo New Energy
DQ
$823M
| $1.47M | ﹤0.01% |
149,935
+126,320
| +535% | +$1.37M |
|
|
CIVI
2204
DELISTED
Civitas Solutions, Inc.
CIVI
| $1.47M | ﹤0.01% |
95,208
+40,131
| +73% | +$611K |
|
2205
Telefônica Brasil
VIV
$22.6B
| $1.47M | ﹤0.01% |
95,355
-117,856
| -55% | -$1.87M |
|
2206
PUT
Rogers Corp
ROG
$2.24B
| $1.46M | ﹤0.01% |
12,200
-3,800
| -24% | -$578K |
|
2207
Varonis Systems
VRNS
$5.33B
| $1.45M | ﹤0.01% |
72,108
-188,472
| -72% | -$3.49M |
|
2208
West Pharmaceutical
WST
$22.9B
| $1.45M | ﹤0.01% |
16,463
-7,667
| -32% | -$717K |
|
2209
Greenlight Captial
GLRE
$570M
| $1.45M | ﹤0.01% |
90,417
+69,463
| +332% | +$1.26M |
|
|
NSTG
2210
DELISTED
NanoString Technologies, Inc.
NSTG
| $1.45M | ﹤0.01% |
192,643
+107,728
| +127% | +$782K |
|
2211
CALL
F5
FFIV
$22.5B
| $1.45M | ﹤0.01% |
10,000
-38,000
| -79% | -$5.45M |
|
2212
Canadian Imperial Bank of Commerce
CM
$108B
| $1.45M | ﹤0.01% |
32,794
-149,464
| -82% | -$7.01M |
|
|
HAYN
2213
DELISTED
Haynes International, Inc.
HAYN
| $1.44M | ﹤0.01% |
38,885
-21,609
| -36% | -$846K |
|
2214
Fresenius Medical Care
FMS
$13.4B
| $1.44M | ﹤0.01% |
28,136
+10,963
| +64% | +$585K |
|
|
BKCC
2215
DELISTED
BlackRock Capital Investment Corporation
BKCC
| $1.44M | ﹤0.01% |
238,131
-116,661
| -33% | -$686K |
|
|
DYN
2216
DELISTED
Dynegy, Inc.
DYN
| $1.44M | ﹤0.01% |
106,224
-226,650
| -68% | -$2.82M |
|
2217
Azenta
AZTA
$1.25B
| $1.44M | ﹤0.01% |
52,988
-102,599
| -66% | -$2.79M |
|
|
SHOE
2218
Shoe Station Group
SHOE
$406M
| $1.43M | ﹤0.01% |
120,226
-164,288
| -58% | -$1.98M |
|
|
BMTC
2219
DELISTED
Bryn Mawr Bank Corp
BMTC
| $1.43M | ﹤0.01% |
32,535
+1,615
| +5% | +$72.8K |
|
2220
CALL
Walt Disney
DIS
$168B
| $1.43M | ﹤0.01% |
14,200
-413,300
| -97% | -$43.9M |
|
2221
The Ensign Group
ENSG
$10.6B
| $1.43M | ﹤0.01% |
57,971
-28,327
| -33% | -$674K |
|
2222
CVR Energy
CVI
$3.35B
| $1.42M | ﹤0.01% |
+46,941
| New | +$1.58M |
|
2223
Independent Bank Corp
IBCP
$782M
| $1.41M | ﹤0.01% |
61,662
+2,872
| +5% | +$67K |
|
|
2224
PUT
EQT Corp
EQT
$32.9B
| $1.41M | ﹤0.01% |
+54,559
| New | +$1.57M |
|
|
ESPR
2225
DELISTED
Esperion Therapeutics
ESPR
| $1.41M | ﹤0.01% |
19,434
+8,978
| +86% | +$659K |
|
Similar funds
D.E. Shaw & Co's Q1 2018 Portfolio in Review
As of Q1 2018, D.E. Shaw & Co held 3,998 positions worth $73.5B, up 1.2% from $72.6B the previous quarter. Its ten largest holdings account for 9.5% of the portfolio.
D.E. Shaw & Co's Q1 2018 filing shows 451 new, 1,293 increased, 1,502 reduced and 554 closed positions. Its largest new stake was GCI Liberty, Inc. Class A Common Stock (DE): 2,434,094 shares worth $129M. The largest sale was Meta Platforms (Facebook), an estimated $694M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 13% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- D.E. Shaw & Co's largest Q1 2018 buy was GCI Liberty, Inc. Class A Common Stock (DE): 2,434,094 shares worth $129M.
- D.E. Shaw & Co added most to Lowe's Companies in Q1 2018, an estimated $638M increase.
- D.E. Shaw & Co's biggest Q1 2018 reduction was Meta Platforms (Facebook), cutting an estimated $694M.
- D.E. Shaw & Co fully exited Liberty Interactive Corporation Series A Liberty Ventures in Q1 2018, selling an estimated $141M.
- D.E. Shaw & Co's ten largest holdings make up 9.5% of its $73.5B portfolio in Q1 2018.
- D.E. Shaw & Co opened 451 new positions and closed 554 in Q1 2018.
- D.E. Shaw & Co's portfolio value rose 1.2% quarter-over-quarter to $73.5B.
Based on D.E. Shaw & Co's 13F filing for Q1 2018, filed 15 May 2018.